DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity

Dyadic International Inc (NASDAQ:DYAI) is in an interesting position, being one of the very few names in the anti-Covid space that offer a new path that isn’t simply a reproduction or tie-in to the big pharma game right now. DYAI has a new approach that isn’t new-age quote-unquote “science”, but a powerful new potential solution […]